HUPO keys on plasma

International group sets priorities in coordinating proteomics efforts.

Written bySteve Bunk
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

SAN DIEGO — Plasma will be the focus of an international effort to plan the emergence of human proteomics, attendees were told at the third annual Human Proteome Project meeting Jan. 15-16. Unlike the human genome, the proteome is multi-dimensional, speakers emphasized. Organs and each of the various body fluids have their own proteomes, which change constantly in response to environmental factors and other signals.

"Human blood plasma represents the deepest and largest version of the human proteome," declared Leigh Anderson, chief executive officer of the Plasma Proteome Institute in Washington, D.C. Assuming that 500 genes generate blood, about 40,000 forms of proteins are secreted in plasma, plus 500,000 forms of tissue protein, and 10 million clonal forms of immunoglobulin, Anderson said.

Faced with such enormous complications, human proteomics researchers are just beginning to integrate technologies into drug discovery, diagnostics, and data management. But big pharma has embraced the field, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies